Cairo – Mubasher: Kahira Pharmaceuticals posted on Wednesday a rise of 96.7% in the company’s profits for the second quarter of fiscal 2016-2017 to EGP 28.5 million, versus EGP 14.49 million for fiscal 2015/16.
In the first half of fiscal 2016/17, profits increased 85.5% to EGP 46.27 million from EGP 24.99 million for the same period of the previous year, according to a bourse filing.
